Relmada Therapeutics, Inc. (RLMD)
2.90
-0.21
(-6.75%)
USD |
NASDAQ |
Nov 20, 10:47
Relmada Therapeutics Free Cash Flow : -51.86M for Sept. 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2026 | -51.86M |
| June 30, 2026 | -45.99M |
| March 31, 2026 | -42.79M |
| December 31, 2025 | -45.79M |
| September 30, 2025 | -39.99M |
| June 30, 2025 | -49.92M |
| March 31, 2025 | -56.79M |
| December 31, 2024 | -51.76M |
| September 30, 2024 | -53.21M |
| June 30, 2024 | -48.18M |
| March 31, 2024 | -48.19M |
| December 31, 2023 | -51.66M |
| September 30, 2023 | -77.29M |
| June 30, 2023 | -92.52M |
| March 31, 2023 | -100.88M |
| December 31, 2022 | -103.80M |
| September 30, 2022 | -105.58M |
| June 30, 2022 | -99.63M |
| March 31, 2022 | -95.22M |
| December 31, 2021 | -91.87M |
| September 30, 2021 | -61.14M |
| June 30, 2021 | -52.73M |
| March 31, 2021 | -40.47M |
| December 31, 2020 | -27.81M |
| September 30, 2020 | -24.55M |
| Date | Value |
|---|---|
| June 30, 2020 | -14.06M |
| March 31, 2020 | -12.25M |
| June 30, 2019 | -10.50M |
| March 31, 2019 | -9.107M |
| December 31, 2018 | -8.720M |
| September 30, 2018 | -6.704M |
| June 30, 2018 | -6.014M |
| March 31, 2018 | -4.757M |
| December 31, 2017 | -5.007M |
| September 30, 2017 | -5.328M |
| June 30, 2017 | -6.516M |
| March 31, 2017 | -8.346M |
| December 31, 2016 | -10.16M |
| September 30, 2016 | -12.66M |
| June 30, 2016 | -13.71M |
| March 31, 2016 | -15.35M |
| December 31, 2015 | -16.09M |
| September 30, 2015 | -17.13M |
| June 30, 2015 | -16.25M |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| February 28, 2014 | -0.0249M |
| September 30, 2013 | -0.4247M |
| August 31, 2013 | -0.0137M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Talphera, Inc. | -12.79M |
| Journey Medical Corp. | -8.621M |
| ANI Pharmaceuticals, Inc. | 199.91M |
| Corcept Therapeutics, Inc. | 194.62M |
| Veru, Inc. | -26.04M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -12.59M |
| Cash from Investing (Quarterly) | 6.954M |
| Cash from Financing (Quarterly) | 0.0177M |
| Free Cash Flow Per Share (Quarterly) | -0.1119 |
| Free Cash Flow to Equity (Quarterly) | -12.59M |
| Free Cash Flow to Firm (Quarterly) | -12.59M |
| Free Cash Flow Yield | -16.76% |